Celltrion
068270.KS
#825
Rank
C$33.43 B
Marketcap
$153.60
Share price
0.22%
Change (1 day)
-14.43%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): C$0.65 Billion

According to Celltrion 's latest financial reports the company's current earnings are C$2.58 Billion. a decrease over its 2023 earnings that were of C$0.71 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 C$0.64 B-8.8%
2023 C$0.71 B6.8%
2022 C$0.66 B-21.85%
2021 C$0.85 B10.25%
2020 C$0.77 B65.16%
2019 C$0.46 B16.64%
2018 C$0.40 B-33.89%
2017 C$0.60 B106.53%
2016 C$0.29 B25.57%
2015 C$0.23 B-6.54%
2014 C$0.25 B47.36%
2013 C$0.16 B-33.63%
2012 C$0.25 B
2010 C$0.13 B72.84%
2009 C$76.88 M260.54%
2008 C$21.32 M